S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
3 Top-Rated, Oversold Industry Giants
Bank Collapse Causes Gold Prices to Soar (Ad)
PayPal Keeps Getting Cheaper; Should You Load Up?
What's Really Behind The FTC's Lawsuit Targeting of Amazon?
Better Than Oil Stocks? (Ad)
Delta Hopes to Soar Again with Customer Loyalty Tweaks
Is the Grinch Stealing This Year's Holiday Season Jobs?
Better Than Oil Stocks? (Ad)
The Next Stage Of Google’s Rally Just Started
Nike, Amicus Therapeutics rise; Vail Resorts, Hess fall, Friday, 9/29/2023
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
3 Top-Rated, Oversold Industry Giants
Bank Collapse Causes Gold Prices to Soar (Ad)
PayPal Keeps Getting Cheaper; Should You Load Up?
What's Really Behind The FTC's Lawsuit Targeting of Amazon?
Better Than Oil Stocks? (Ad)
Delta Hopes to Soar Again with Customer Loyalty Tweaks
Is the Grinch Stealing This Year's Holiday Season Jobs?
Better Than Oil Stocks? (Ad)
The Next Stage Of Google’s Rally Just Started
Nike, Amicus Therapeutics rise; Vail Resorts, Hess fall, Friday, 9/29/2023
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
3 Top-Rated, Oversold Industry Giants
Bank Collapse Causes Gold Prices to Soar (Ad)
PayPal Keeps Getting Cheaper; Should You Load Up?
What's Really Behind The FTC's Lawsuit Targeting of Amazon?
Better Than Oil Stocks? (Ad)
Delta Hopes to Soar Again with Customer Loyalty Tweaks
Is the Grinch Stealing This Year's Holiday Season Jobs?
Better Than Oil Stocks? (Ad)
The Next Stage Of Google’s Rally Just Started
Nike, Amicus Therapeutics rise; Vail Resorts, Hess fall, Friday, 9/29/2023
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
3 Top-Rated, Oversold Industry Giants
Bank Collapse Causes Gold Prices to Soar (Ad)
PayPal Keeps Getting Cheaper; Should You Load Up?
What's Really Behind The FTC's Lawsuit Targeting of Amazon?
Better Than Oil Stocks? (Ad)
Delta Hopes to Soar Again with Customer Loyalty Tweaks
Is the Grinch Stealing This Year's Holiday Season Jobs?
Better Than Oil Stocks? (Ad)
The Next Stage Of Google’s Rally Just Started
Nike, Amicus Therapeutics rise; Vail Resorts, Hess fall, Friday, 9/29/2023
NYSE:HAE

Haemonetics (HAE) SEC Filings & 10K Form

$89.58
-1.58 (-1.73%)
(As of 09/29/2023 ET)
Compare
Today's Range
$89.24
$92.73
50-Day Range
$84.95
$93.49
52-Week Range
$72.26
$95.26
Volume
336,065 shs
Average Volume
332,648 shs
Market Capitalization
$4.54 billion
P/E Ratio
33.80
Dividend Yield
N/A
Price Target
$103.67

Recent Haemonetics SEC Filings

DateFilerForm TypeView
09/18/2023
3:16 PM
Haemonetics (Issuer)
Miller Laurie A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2023
3:19 PM
Haemonetics (Issuer)
Strong Stewart W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2023
3:20 PM
Haemonetics (Issuer)
Lingamneni Anila (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2023
11:19 AM
Haemonetics (Subject)
Strong Stewart W (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/11/2023
12:22 PM
Haemonetics (Subject)
Lingamneni Anila (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/07/2023
3:23 PM
Dockendorff Charles J (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2023
1:23 PM
Dockendorff Charles J (Reporting)
Haemonetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/08/2023
5:09 AM
Haemonetics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2023
5:01 AM
Haemonetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/20/2023
3:17 PM
Haemonetics (Issuer)
Llorens Josep (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2023
11:55 AM
Haemonetics (Subject)
Llorens Josep (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/30/2023
3:17 PM
Haemonetics (Issuer)
Simon, Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
5:14 AM
Haemonetics (Filer)
Form ARS
06/16/2023
5:08 AM
Haemonetics (Filer)
Form DEF 14A
06/16/2023
5:10 AM
Haemonetics (Filer)
Form DEFA14A
06/07/2023
1:03 PM
Haemonetics (Subject)
Strong Stewart W (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/01/2023
3:19 PM
Haemonetics (Issuer)
Lingamneni Anila (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2023
9:23 AM
Haemonetics (Subject)
Lingamneni Anila (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/19/2023
3:37 PM
Basil Michelle L (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2023
3:34 PM
Haemonetics (Issuer)
Miller Laurie A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2023
3:35 PM
Haemonetics (Issuer)
Strong Stewart W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2023
3:36 PM
Haemonetics (Issuer)
Maunsell Farris Maryanne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2023
3:16 PM
Haemonetics (Issuer)
Llorens Josep (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2023
3:17 PM
Basil Michelle L (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2023
5:05 AM
Haemonetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/18/2023
5:07 PM
Haemonetics (Issuer)
Lingamneni Anila (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2023
1:10 PM
Haemonetics (Subject)
Neuberger Berman Group LLC (Filed by)
Form SC 13G/A
02/09/2023
10:22 AM
Haemonetics (Subject)
Form SC 13G/A
02/07/2023
5:09 AM
Haemonetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/07/2023
5:17 AM
Haemonetics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
01/25/2023
3:28 PM
Haemonetics (Issuer)
Llorens Josep (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2022
3:40 PM
Haemonetics (Issuer)
Simon, Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2022
5:03 AM
Haemonetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/03/2022
3:54 PM
Galvin Roy (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/26/2022
3:35 PM
Basil Michelle L (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/26/2022
3:43 PM
Haemonetics (Issuer)
Strong Stewart W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/19/2022
4:22 PM
Haemonetics (Issuer)
Maunsell Farris Maryanne (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/19/2022
4:15 PM
Haemonetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2022
7:19 PM
Galvin Roy (Reporting)
Haemonetics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/11/2022
9:07 AM
Haemonetics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NYSE:HAE) was last updated on 9/30/2023 by MarketBeat.com Staff

My Account -